SCHEMBL7412388

SCHEMBL7412388

C[C@@H](C(=O)N[C@@H](CCCc1ccccc1)CC(N)=O)N(C(=O)N1CCOCC1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CTSS P25774 11/20 0.42
CTSL P07711 4/20 0.41
CTSK P43235 4/20 0.41
MMP1 P03956 1/20 0.41
MMP3 P08254 1/20 0.41
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.39
FKBP1A P62942 1/20 0.39
ALDH1A1 P00352 1/20 0.38
KMT2A Q03164 1/20 0.38
MLYCD O95822 1/20 0.38
CTSB P07858 2/20 0.37
CTSH P09668 1/20 0.37
CTSC P53634 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7028324 0.79 CTSL (0.51) CTSSCTSLCTSKMMP8FKBP1A
SCHEMBL8690335 0.79 CTSS (0.46) CTSSCTSLCTSKMMP8FKBP1A
SCHEMBL7356291 0.78 FKBP1A (0.41) CTSSCTSLCTSKMMP1MMP3
SCHEMBL7378602 0.76 CTSS (0.45) CTSSCTSLCTSKALDH1A1CTSB
SCHEMBL7545314 0.73 CTSS (0.62) CTSSCTSLCTSBCTSC
SCHEMBL8696245 0.72 MMP2 (0.42) CTSSCTSLCTSKALDH1A1KMT2A
SCHEMBL8696240 0.72 MMP2 (0.42) CTSSCTSLCTSKALDH1A1KMT2A
SCHEMBL7445245 0.72 ALDH1A1 (0.57) ALDH1A1KMT2A
SCHEMBL7546891 0.70 CTSS (0.60) CTSSCTSLALDH1A1CTSBCTSC
SCHEMBL6450679 0.69 CTSB (0.38) CTSSCTSLCTSKMMP9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5776718-A Reversible protease inhibitors ARRIS PHARMACEUTICAL CORPORATION (US) 1998-07-07 US disclosed
EP-0817778-A1 REVERSIBLE PROTEASE INHIBITORS ARRIS PHARMACEUTICAL CORPORATION (US) 1998-01-14 EP disclosed
WO-1996030353-A1 REVERSIBLE PROTEASE INHIBITORS ARRIS PHARMACEUTICAL CORPORATION (US) 1996-10-03 WO disclosed